ALLIE CHILDERS: Open Payments
NPI 1811733645 · CALHOUN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 27 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $94 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| ACADIA Pharmaceuticals Inc | 3 | $62 |
| Lilly USA, LLC | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Exact Sciences Corporation | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
Products named: JARDIANCE, CAPLYTA, DAYBUE, Ozempic, Rybelsus, ELIQUIS, TRELEGY ELLIPTA, Cologuard Collection Kit.
Industry payments across GA — which companies pay providers there.
